GTL001, a Therapeutic Vaccine for Women Infected With Human Papillomavirus 16 or 18 and Normal Cervical Cytology: Results of a Phase I Clinical Trial
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-16-0085
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2016
Authors
Publisher
American Association for Cancer Research (AACR)